Crossref
Endocan (ESM-1): a new marker of endothelial dysfunction. Biology, pathophysiology, and clinical applications
Sang Thrombose Vaisseaux · 2026-10 · 38 (5) · 189-198
DOI: 10.1684/stv.2026.1365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sang Thrombose Vaisseaux, 2026-10. Verfasst von Bernard I. Lévy.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lévy, B. I. (2026). Endocan (ESM-1): a new marker of endothelial dysfunction. Biology, pathophysiology, and clinical applications. Sang Thrombose Vaisseaux, 38(5), 189-198. https://doi.org/10.1684/stv.2026.1365
Vancouver
Lévy BI. Endocan (ESM-1): a new marker of endothelial dysfunction. Biology, pathophysiology, and clinical applications. Sang Thrombose Vaisseaux. 2026;38(5):189-198. doi:10.1684/stv.2026.1365
BibTeX
@article{Lvy2026,
author = {Lévy, Bernard I.},
title = {Endocan (ESM-1): a new marker of endothelial dysfunction. Biology, pathophysiology, and clinical applications},
journal = {Sang Thrombose Vaisseaux},
year = {2026},
volume = {38},
number = {5},
pages = {189--198},
doi = {10.1684/stv.2026.1365}
}
EUVIMED